These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6409812)

  • 1. Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Mori Y; Sakuta M; Kawasaki A; Inage M; Kusumoto S; Shiba T; Kasai N
    Infect Immun; 1983 Aug; 41(2):758-73. PubMed ID: 6409812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.
    Takada H; Kotani S; Tsujimoto M; Ogawa T; Takahashi I; Harada K; Katsukawa C; Tanaka S; Shiba T; Kusumoto S
    Infect Immun; 1985 Apr; 48(1):219-27. PubMed ID: 3980084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
    Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.
    Kotani S; Takada H; Takahashi I; Tsujimoto M; Ogawa T; Ikeda T; Harada K; Okamura H; Tamura T; Tanaka S
    Infect Immun; 1986 Jun; 52(3):872-84. PubMed ID: 3011676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiological activities of synthetic lipid A analogs with low endotoxicity.
    Kotani S; Takada H; Takahashi I; Ogawa T; Tsujimoto M; Shimauchi H; Ikeda T; Okamura H; Tamura T; Harada K
    Infect Immun; 1986 Dec; 54(3):673-82. PubMed ID: 3781622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis.
    Ogawa T
    Eur J Biochem; 1994 Feb; 219(3):737-42. PubMed ID: 8112323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Harada K; Mori Y; Kawasaki A; Tanaka A; Nagao S; Tanaka S
    Infect Immun; 1984 Jul; 45(1):293-6. PubMed ID: 6735470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
    Shimizu T; Ohtsuka Y; Yanagihara Y; Itoh H; Nakamoto S; Achiwa K
    Int J Immunopharmacol; 1991; 13(5):605-11. PubMed ID: 1783474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A.
    Tanamoto K; Galanos C; Lüderitz O; Kusumoto S; Shiba T
    Infect Immun; 1984 May; 44(2):427-33. PubMed ID: 6715043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
    Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
    Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.
    Byars NE
    Infect Immun; 1984 May; 44(2):344-50. PubMed ID: 6609127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of murine B cell clonal expansions by synthetic lipid A and muramyl dipeptide analogs.
    Saito-Taki T; Nakano M; Kiso M; Hasegawa A
    Microbiol Immunol; 1985; 29(11):1111-20. PubMed ID: 2419740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).
    Ogawa T; Suda Y; Kashihara W; Hayashi T; Shimoyama T; Kusumoto S; Tamura T
    Vaccine; 1997 Oct; 15(15):1598-605. PubMed ID: 9364689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.
    Takahashi I; Kotani S; Takada H; Tsujimoto M; Ogawa T; Shiba T; Kusumoto S; Yamamoto M; Hasegawa A; Kiso M
    Infect Immun; 1987 Jan; 55(1):57-68. PubMed ID: 3539807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of the proliferative response of thymocytes to phytohemagglutinin by the muramyl dipeptide1.
    Iribe H; Koga T
    Cell Immunol; 1984 Oct; 88(1):9-15. PubMed ID: 6332683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities.
    Takada H; Kawabata Y; Arakaki R; Kusumoto S; Fukase K; Suda Y; Yoshimura T; Kokeguchi S; Kato K; Komuro T
    Infect Immun; 1995 Jan; 63(1):57-65. PubMed ID: 7806384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
    Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
    Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant activities of synthetic lipid A subunit analogues and its conjugates with muramyl dipeptide derivatives.
    Maeda H; Saiki I; Ishida H; Kiso M; Hasegawa A; Azuma I
    Vaccine; 1989 Jun; 7(3):275-81. PubMed ID: 2675486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Salmonella-type lipid A antigen with high serological specificity.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S; Imoto M
    Infect Immun; 1986 Jan; 51(1):43-8. PubMed ID: 3941004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogenic and polyclonal B cell activation activities of synthetic lipid A analogues.
    Kumazawa Y; Matsuura M; Nakatsuru-Watanabe Y; Fukumoto M; Nishimura C; Homma JY; Inage M; Kusumoto S; Shiba T
    Eur J Immunol; 1984 Feb; 14(2):109-14. PubMed ID: 6199209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.